Trials Sponsors Conditions Drugs Pricing

Conditions

Lung Cancer Protection Against Malignant Lung Neoplasm (Diagnosis)

Keywords

lung cancertobacco cessationrespiratory assessment

Outcome Measures

Primary Outcomes (3)

Incidence of lung cancer in early stage in a high risk population during a lung cancer screening programme. We measure this outcome depending on the CT results.
Lung cancer screening
0 years until 5 years
The number of patients who quit smoking during a lung cancer screening program. We will measure this parameter by recording smoking cessation during the 5 years.
Tobacco Cessation
0 years until 5 years
The number of patients who present other diseases associated with smoking such as emphysema, COPD or coronary pathology. We will measure this parameter by means of spirometry and CT scan.
Respiratory assessment
0 years until 5 years

Study Arms (1)

Active smokers

OTHER

We do a CT scan in active smokers and ex-smokers plus an spirometry combined to a tobacco cessation programme in active smokers

Diagnostic Test: Lung cancer screening with low dose CT scan

Interventions

Lung cancer screening with low dose CT scanDiagnostic test

Low dose CT scan in active smokers or ex-smokers with an age between 50 and 75 years old

Active smokers

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age50 Years - 75 Years

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Age 50-75 years active smoker with cumulative dose of \>20 packets/year
Age 50-75 years ex-smoker less than 15 years old with cumulative dose of \> 20 packets/year

You may not qualify if:

Sponsors & Collaborators

Sociedad Española de Neumología y Cirugía Torácica
Othercollaborator
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Otherlead

MeSH Terms

Conditions

Lung NeoplasmsDiseaseTobacco Use Cessation

Interventions

Tomography, X-Ray Computed

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsHealth BehaviorBehavior

Study Officials

Juan Carlos Trujillo Reyes, MD/PHD
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
STUDY DIRECTOR

Central Study Contacts

Juan Carlos Trujillo Reyes, MD/PHD

CONTACT

0034654032813 jtrujillo@santpau.cat

Luis Seijo Maceiras, MD/PHD

CONTACT

lseijo@unav.es

Study Design

Study Type: interventional
Phase: not applicable
Allocation: NA
Masking: NONE
Purpose: SCREENING
Intervention Model: SINGLE GROUP
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

November 24, 2023

First Posted

December 6, 2023

Study Start

December 31, 2023

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Primary Completion

December 31, 2024

Estimated (date passed)

Cancer Screening Smoking Cessation AND Respiratory Assessment

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (3)

Study Arms (1)

Active smokers

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

Intervention Hierarchy (Ancestors)

Data Sharing

Source record

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (3)

Study Arms (1)

Active smokers

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

Intervention Hierarchy (Ancestors)

Data Sharing

Source record